XNAS
QSI
Market cap241mUSD
Oct 08, Last price
1.22USD
1D
-4.69%
1Q
38.21%
IPO
-87.68%
Name
Quantum-Si Inc
Chart & performance
P/E
—
P/S
99.64
EPS
—
Div yield, %
—
Shrs. gr., 5y
105.64%
Rev. gr., 5y
%
Revenues
2m
-20.34%
Net income
-101m
L+0.33%
CFO
-95m
L+7.88%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Quantum-Si, Inc. is a life sciences company focused on revolutionizing the growing field of proteomics. It engages in the development of a proprietary universal single-molecule detection platform to enable Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins in a massively parallel fashion. Its platform includes platinum NGPS instrument, platinum analysis software, and consumable kits for platinum instrument. The company was founded by Jonathan M. Rothberg on June 24, 2013 and is headquartered in Branford, CT.
Key people
Jeffrey Hawkins
President, Chief Executive Officer, Director · since 2023
Jeffry Keyes
Chief Financial Officer, Treasurer · since 2024
Chief Commercial Officer · since 2024
John Vieceli
Chief Product Officer · since 2024
Christian LaPointe
General Counsel, Corporate Secretary · since 2021
Independent Director · since 2024
Independent Director · since 2021
Amir Jafri
Independent Director · since 2023
Independent Director · since 2023
Independent Non-Executive Chairman of the Board · since 2024
Independent Director · since 2021
Independent Director · since 2023
Independent Director · since 2020
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||